Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|December 4, 2013
AJPB® Translating Evidence-Based Research Into Value-Based Decisions®
- Specialty Pharmacy
- Volume 5
- Issue 6
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis Patients
Among rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Advertisement
This study supports earlier research on the comparative effectiveness of tumor necrosis factor (TNF) blockers in rheumatoid arthritis (RA) patients, but is unique in utilizing both clinical outcomes data from US clinical practices and actual drug utilization data from claims.
- Increased costs resulting from TNF blocker dose escalation may not always be accompanied by an improvement in clinical benefit.
- In the current comparative effectiveness research paradigm, understanding the clinical benefit gained from additional cost is critical to payers.
- Among RA patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Articles in this issue
almost 13 years ago
Practice Economics and the Decision to Prescribe Oral Oncolyticsalmost 13 years ago
Specialty Pharmacy Improves Adherence to Imatinibalmost 13 years ago
The Role of Specialty Drugs in Private Sector Healthcare Spendingalmost 13 years ago
Genetic Testing: Front and Centeralmost 13 years ago
A Medical Director Perspective on Specialty PharmacyAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
4
Baseline Interferon Activity in Monocytes Predicts mRNA Vaccine Adverse Effects, Study Finds
5